Interleukin-27 Subunit alpha (IL27) Kits ELISA

The protein encoded by IL27 is one of the subunits of a heterodimeric cytokine complex. De plus, nous expédions IL27 Anticorps (18) et et beaucoup plus de produits pour cette protéine.

list all ELISA KIts Gène GeneID UniProt
IL27 246779 Q8K3I6
IL27 246778 Q8NEV9
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne

Top IL27 Kits ELISA sur

Showing 2 out of 3 products:

Catalogue No. Reactivité Sensibilité Gamme Images Quantité Fournisseur Livraison Prix Détails
Souris < 7.81 pg/mL 15.6 pg/mL - 1000 pg/mL   96 Tests Connectez-vous pour afficher 11 to 18 Days
Humain 18.75 pg/mL 31.25 pg/mL - 2000 pg/mL   96 Tests Connectez-vous pour afficher 11 to 18 Days

Plus Kits ELISA pour IL27 partenaires d'interaction

Mouse (Murine) Interleukin-27 Subunit alpha (IL27) interaction partners

  1. IL30 plays an important role in regulating prostate cancer stem-like cell behavior and metastatic potential, therefore targeting this cytokine could hamper prostate cancer progression or recurrence

  2. IL-27Ra-deficient Tregs and STAT1-deficient Tregs were less efficient than WT Tregs in suppressing antitumor immunity in vivo. CD39 inhibition significantly abolished IL-27-induced suppressive activities of Tregs. Thus, IL-27 signaling in Tregs critically contributes to protumorigenic properties of Tregs via up-regulation of CD39.

  3. IL-27 is essential for the generation of IL-10-producing effector cells in primary infection by MHV68.

  4. IL-27 induces IL-10 production in CD4 T cells during mouse cytomegalovirus infection.

  5. data suggested that IL-27/IL-27R expression induced by Toxoplasma gondii infection may regulate mast cell-mediated immune response during acute ocular toxoplasmosis in mouse model

  6. IL-27 has a unique ability to directly act on hematopoietic stem cells and promote their expansion and differentiation into myeloid progenitors in hematologic neoplasms and malaria. (Review)

  7. Mechanistic studies have identified that hyperlipidemia induces IL-27 production in a TLR4-dependent manner, likely via downregulating LXR expression in dendritic cells. In this case, mice lacking IL-27 do not develop enhanced antibody responses.

  8. IFN-gamma induces IL-30 production which suppresses IFN-gamma mediated liver inflammation.

  9. IL-27 signaling in Foxp3(+) Tregs essential for Tregs to control autoimmune inflammation in the central nervous system

  10. this study indicates that IL-27 secreted by cervical carcinoma cells restricts the angiogenesis in a paracrine manner in the pathogenesis of cervical cancer

  11. this study has revealed an important role of thymic dendritic cells-derived IL-27 in the regulation of the phenotypic maturation of CD4(+) single positive thymocytes.

  12. TTP, encoded by Zfp36, degrades p28 to inhibit IL-27 production by macrophages and is thereby a negative regulator of the antitumour response.

  13. these data infer that endopeptidase mediated gliadin degradation by macrophages and concomitant IL-27 production drive differentiation of splenic gliadin-specific Tr1-like cells in celiac disease

  14. endogenous levels of IL-27 affected the oncogenic properties of mutant p53 in vivo in a Li-Fraumeni mouse model. Lack of IL-27 signaling led to shortened survival times and increased incidence of osteosarcomas.

  15. Interleukin-27 is upregulated centrally and peripherally after intracerebral hemorrhage. Interleukin-27 promotes the tissue-protecting functions of neutrophils via, at least partly, the induction of lactoferrin.

  16. Serum IL-27 levels and cardiac IL-27 mRNA expression were significantly increased after LPS injection compared with control specimens.

  17. these findings highlight critical roles for IFN-gamma and IL-27 in the mechanism of respiratory syncytial virus-induced exacerbation

  18. IL-27-induced Sca-1(+) T cells had increased expression of effector/memory-associated transcription factor T-bet, Eomes and Blimp1.

  19. found that during respiratory virus infection the prototypic inflammatory cytokine IL-6 is a critical anti-inflammatory regulator of viral induced immunopathology in the respiratory tract through its induction of IL-27

  20. We demonstrate that IL-27-deficiency is linked to increased mucosal presence of ILC2 in a model of inflammatory lung disease. Moreover, IL-27-treatment inhibited ILC2 proliferation and cytokine production and significantly reduced their accumulation in vivo.

Human Interleukin-27 Subunit alpha (IL27) interaction partners

  1. Study found no statistically significant difference between the studied groups regarding the IL-27p28 genotypes and revealed that TNF-alpha rs1800629 polymorphism is a potential genetic-susceptibility factor for hepatitis C virus related cirrhosis and hepatocellular carcinoma progression in Egyptian patients.

  2. In vitro IL-8 production by IL-27 and IL-37 pre-treated neutrophils and monocytes was significantly inhibited.

  3. A total of 885 septic patients and 1101 healthy controls were enrolled and genotyped for IL-27 genetic variants (rs153109/-964A > G and rs17855750/2905 T > G). Quantitative real-time PCR and enzyme-linked immunosorbent assays were performed to detect IL-27 expression and cytokine production. The effect of the rs153109 polymorphism on IL-27 promoter activity was evaluated using a luciferase reporter assay, and THP-1 cell a

  4. elevated IL-27 correlated well with bacterial sepsis among neonatal patients with bloodstream infections

  5. Impaired TLR-induced IL-27 secretion and augmented expression of antigen presentation molecules result in chronic T cell activation which may fuel T cell-mediated inflammation in type-2 diabetes.

  6. Serum levels of IL-27 were decreased in patients with Parkinson's disease compared to those in healthy subjects.

  7. Early-stage non-small cell lung cancer is characterized by high IL-27 expression in the lower airways.

  8. IL-27 production was elevated during Clostridium difficile infection in humans and mice. Infected WSX-1-/- mice experienced increased weight loss, enhanced colonic histology damage, less Clostridium difficile clearance, and decreased survival compared to wild-type controls during Clostridium difficile infection.

  9. In humans only heterodimeric IL-27 is present.

  10. the efficacy of IL-27 in inhibiting endotoxin tolerance in human THP-1 monocytes and PMA-THP-1 macrophages is affected by membrane-bound and soluble CD14 expression.

  11. SMM do not induce the production of TNF-alpha and other cytokines while inhibiting LPS-induced IL-27 production by inhibiting the classical NF-kappaB pathway.

  12. IL-27 serum levels were significantly differences in early onset and late onset severe preeclampsia than in gestation matched healthy pregnancies (p=0.0376, p=0.0085, respectively). Our results suggest IL-27 might be a useful biomarker for disease severity in preeclampsia.

  13. Over-expression of IL-17 and IL-27 are involved in the pathogenesis of liver damage in children with human cytomegalovrius infection.

  14. Interleukin-27 differentially regulates the expression of seven novel microRNAs.

  15. Patients with tuberculous pleural effusion have an about 26-fold higher chance of being IL-27 test-positive compared to patients with malignant pleural effusion. [meta-analysis]

  16. there was a significant increase in the risk of Kawasaki disease with coronary arterial lesions in children with the rs17855750 (T>G), rs40837 (A>G), rs4740 (G>A), rs4905 (A>G), rs153109 (T>C), and rs26528 (A>G) Single-nucleotide Polymorphisms.

  17. our results showed that SNP rs153109 displayed significant associations with dilated cardiomyopathy in Chinese Han population, whereas no differences in genotype or allele frequencies were found between dilated cardiomyopathy patients and controls at SNP rs17855750.

  18. Human Immunodeficiency virus type-1 myeloid derived suppressor cells inhibit cytomegalovirus inflammation through IL-27 and B7-H4.

  19. IL-27 enhances the potential of reactive oxygen species generation from monocyte-derived macrophages and dendritic cells by induction of p47(phox).

  20. IL-27 has a unique ability to directly act on hematopoietic stem cells and promote their expansion and differentiation into myeloid progenitors in hematologic neoplasms and malaria. (Review)

IL27 profil antigène

Antigen Summary

The protein encoded by this gene is one of the subunits of a heterodimeric cytokine complex. This protein is related to interleukin 12A (IL12A). It interacts with Epstein-Barr virus induced gene 3 (EBI3), a protein similar to interleukin 12B (IL12B), and forms a complex that has been shown to drive rapid expansion of naive but not memory CD4(+) T cells. The complex is also found to synergize strongly with interleukin 12 to trigger interferon gamma (IFNG) production of naive CD4(+) T cells. The biological effects of this cytokine are mediated by the class I cytokine receptor (WSX1/TCRR).

Gene names and symbols associated with IL27

  • interleukin 27 (Il27) anticorps
  • interleukin 27 (IL27) anticorps
  • IL-27 anticorps
  • IL-27A anticorps
  • IL-27p28 anticorps
  • IL27A anticorps
  • IL27p28 anticorps
  • IL30 anticorps
  • p28 anticorps

Protein level used designations for IL27

IL-27 p28 subunit , IL-27 subunit alpha , IL-27-A , IL27-A , interleukin 30 , interleukin-27 subunit alpha

246779 Mus musculus
246778 Homo sapiens
Fournisseurs de qualité sélectionnés pour IL27 (IL27) Kits ELISA
Avez-vous cherché autre chose?